Clinical Research Directory
Browse clinical research sites, groups, and studies.
Personalized Radiation Therapy for GBM
Sponsor: Abramson Cancer Center at Penn Medicine
Summary
The study is a pilot study to estimate the efficacy of personalized dose-escalation radiation therapy in patients with glioblastoma, as measured by estimating the median of progression-free survival. Toxicity, patterns of recurrence, and overall median survival will be measured as secondary endpoints. Adverse events will be monitored.
Official title: Personalized Treatment of Glioblastoma Via Image-Guided Predictive Modeling of Recurrence: A Single-Arm, Single Institutional Pilot Prospective Study of Dose-Escalated Radiation Therapy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2018-03-01
Completion Date
2026-07-30
Last Updated
2025-06-18
Healthy Volunteers
No
Conditions
Interventions
Radation Therapy
Personalized Radiation Therapy
Locations (1)
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States